Abstract

Engagement of the Fas receptor promotes apoptosis by activation of caspases. In addition, alterations in plasma membrane lipid orientation and intracellular ceramide levels are often observed. In A20 B-lymphoma cells, FasL-induced cell death and phosphatidylserine (PS) externalization were completely prevented by the generic caspase inhibitor z-VAD-fmk. By contrast, the caspase-3 inhibitor Ac-DEVD-cho only partially restored cell viability and had no effect on surface exposure of PS. Flow cytometric analysis after FasL treatment identified two populations of dead cells. In one, death was dependent on caspase-3 and paralleled by DNA fragmentation and cell shrinkage. In the second, death occurred in the absence of caspase-3 activity and apoptotic features but was also blocked by zVAD-fmk. By morphological criteria these were identified as apoptotic and necrotic cells, respectively. Using fluorescent substrates, caspase-3 activity was detected only in the apoptotic cell population, whereas caspase-8 activity was detected in both. Both forms of caspase-8-dependent cell death were also detected downstream of Fas in Jurkat T-cells, where Fas-dependent PS externalization and delayed ceramide production, which is similar to results shown here in A20 cells, have been reported. However, for Raji B-cells, lacking lipid scrambling and ceramide production in response to Fas activation, only apoptosis was detected. Short-chain C2- or C6-ceramides, but not the respective inactive dihydro compounds or treatment with bacterial sphingomyelinase, induced predominantly necrotic rather than apoptotic cell death in A20 B-, Raji B- and Jurkat T-cells. Thus, delayed elevation of ceramide is proposed to promote necrosis in those Fas-stimulated cells where caspase-8 activation was insufficient to trigger caspase-3-dependent apoptosis.

Highlights

  • The interaction between FasL and the Fas (Apo-1/CD95) receptor plays an essential role in the control of T- and B-cell activity and maintenance of immunological tolerance

  • Ac-DEVD-cho treatment of A20 B-lymphoma cells revealed an alternative death signaling pathway originating from Fas

  • AcYVAD-cho had no effect at the same concentration on either dead cell population observed in response to FasL, whereas zVAD-fmk eliminated both

Read more

Summary

Introduction

The interaction between FasL and the Fas (Apo-1/CD95) receptor plays an essential role in the control of T- and B-cell activity and maintenance of immunological tolerance. Repeated antibody stimulation of CD4+ T-cells results in high levels of Fas and FasL expression and, as a consequence, these cells die (Abbas, 1996; Cornall et al, 1995; Matiba et al, 1997; Nagata, 1997). Fas is involved in the elimination of active or autoreactive B-lymphocytes (Cornall et al, 1995; Nagata, 1997). FasL binding stabilizes the trimeric form of the Fas receptor, thereby allowing recruitment of the Fas-associated death domain (DD)-containing protein (FADD). Many cellular proteins are degraded, leading to cell death

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call